American Century Companies’s Kyntra Bio KYNB Stock Holding History

American Century Companies’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,023	Closed	-$7.34M	–	2302
2021 Q2	$7.34M	Buy	11,023 +39	+0.4%	+$22.5K	0.01%	895
2021 Q1	$9.53M	Sell	10,984 -228	-2%	-$243K	0.01%	788
2020 Q4	$10.4M	Sell	11,212 -174	-2%	-$183K	0.01%	756
2020 Q3	$11.7M	Sell	11,386 -650	-5%	-$699K	0.01%	677
2020 Q2	$12.2M	Buy	12,036 +4,908	+69%	+$4.56M	0.01%	630
2020 Q1	$6.19M	Sell	7,128 -188	-3%	-$187K	0.01%	693
2019 Q4	$7.84M	Buy	7,316 +3,867	+112%	+$3.95M	0.01%	733
2019 Q3	$3.19M	Buy	3,449 +204	+6%	+$224K	﹤0.01%	890
2019 Q2	$3.67M	Sell	3,245 -8	-0.2%	-$8.76K	﹤0.01%	904
2019 Q1	$4.42M	Sell	3,253 -378	-10%	-$513K	﹤0.01%	841
2018 Q4	$4.2M	Buy	3,631 +48	+1%	+$54K	﹤0.01%	847
2018 Q3	$5.44M	Sell	3,583 -26	-0.7%	-$40K	0.01%	839
2018 Q2	$5.65M	Buy	3,609 +211	+6%	+$275K	0.01%	828
2018 Q1	$3.92M	Buy	3,398 +52	+2%	+$68.5K	﹤0.01%	884
2017 Q4	$3.96M	Buy	3,346 +931	+39%	+$1.17M	﹤0.01%	891
2017 Q3	$3.25M	Sell	2,415 -7,443	-76%	-$7.84M	﹤0.01%	951
2017 Q2	$7.96M	Sell	9,858 -144	-1%	-$100K	0.01%	728
2017 Q1	$6.16M	Buy	10,002 +2,590	+35%	+$1.58M	0.01%	814
2016 Q4	$3.96M	Sell	7,412 -2,737	-27%	-$1.37M	﹤0.01%	905
2016 Q3	$5.25M	Buy	10,149 +948	+10%	+$447K	0.01%	862
2016 Q2	$3.77M	Buy	9,201 +7,250	+372%	+$3.32M	﹤0.01%	911
2016 Q1	$1.04M	Buy	1,951 +699	+56%	+$348K	﹤0.01%	1093
2015 Q4	$954K	Buy	1,252 +78	+7%	+$51.8K	﹤0.01%	1117
2015 Q3	$644K	Buy	+1,174	New	+$711K	﹤0.01%	1185

Other funds holding KYNB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies's KYNB Position: Q3 2021 in Review

American Century Companies sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 11,023 shares — an estimated $7.34M sold.

American Century Companies first reported a position in KYNB in Q3 2015 and held it in 24 quarters. The position peaked at $12.2M in Q2 2020. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

American Century Companies reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
American Century Companies sold 11,023 Kyntra Bio shares in Q3 2021, an estimated $7.34M.
American Century Companies first reported a position in Kyntra Bio in Q3 2015 and held it in 24 quarters.
American Century Companies's Kyntra Bio position peaked at $12.2M in Q2 2020.
164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on American Century Companies's 13F filing for Q3 2021, filed 10 Nov 2021.